10 Discounted Stocks That Could Surprise This Earnings Season

The article highlights 10 undervalued U.S. stocks set to report earnings within 10 days, with estimated fair value upside of roughly 36% to 60% and analyst upside of about 22% to 117%. It spotlights Churchill Downs (about 53% implied upside, earnings April 22), Gentex (over 23% upside), and Omnicell (earnings April 28, FY2026 EPS guidance of $1.65-$1.85). The piece is largely a screening and idea-generation article, so the near-term market impact is limited despite the earnings catalysts.

Analysis

This setup is less about "cheap stocks" and more about dispersion around an earnings inflection. The screen is effectively isolating names where sentiment is still lagging fundamentals, so the first-order opportunity is not in direction alone but in the mismatch between already-low positioning and the size of any guidance surprise. That favors CHDN and OMCL most: both have plausible multi-quarter rerating paths if management confirms margin durability and capital allocation discipline, while GNTX is more of a quality compounder that needs only modest revisions to work.

The key second-order effect is that earnings can reset valuation anchors faster than business changes. If CHDN shows even incremental resilience into Derby season, the market may start capitalizing its cash flow more like a gaming/entertainment platform than a regional leisure asset, which widens the buyer base and compresses the discount rate applied to future growth. OMCL’s risk/reward is different: any evidence that software mix is scaling can trigger multiple expansion before the revenue model fully inflects, because investors will pay ahead of the margin shift rather than the earnings itself.

The contrarian read is that analyst upside may be overstating near-term upside because the market is likely already pricing in "good enough" numbers after a volatile quarter. The real asymmetry is on misses: if managements sound cautious, the stocks with the highest implied upside can de-rate 10-20% quickly, especially names where the valuation case depends on future margin assumptions rather than current earnings power. GNTX looks like the cleaner relative long because the balance sheet and cash generation reduce blow-up risk, while AAL is essentially a market sentiment placeholder with no edge from this setup and should only be traded tactically around results.

Key Decisions for Investors

• Long CHDN into earnings with a 2-4 week horizon; target a post-print rerating if commentary supports stable demand and margin resilience. Risk/reward is favorable because positioning is likely light, but trim aggressively if management turns cautious on consumer spend.
• Initiate a small long OMCL / short AAL pair into the release window. OMCL offers a multi-quarter software-mix story that can re-rate on guidance, while AAL is a lower-conviction earnings trade with more macro sensitivity than company-specific upside.
• Buy GNTX on any pre-earnings weakness and hold through the print as a lower-volatility earnings play. The setup favors modest upside rather than a dramatic breakout, so use tight downside discipline and look to monetize on a 5-10% move.
• Avoid chasing AAL ahead of earnings; if anything, use short-dated put spreads as a hedge against a weak guidance cycle. The trade works only if travel demand or unit-cost commentary disappoints, so keep size small and event-driven.
• For OMCL, consider call spreads rather than outright stock into the print to express the SaaS-transition thesis with defined downside. The market may reward incremental evidence of mix shift even if headline results remain messy, making convexity more attractive than delta.